Ironwood Pharmaceuticals Sees FY2025 Sales $260.000M-$290.000M vs $270.600M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Ironwood Pharmaceuticals (NASDAQ:IRWD) sees FY2025 sales of $260.000 million-$290.000 million vs $270.600 million analyst estimate.
Ironwood Pharmaceuticals (NASDAQ:IRWD) sees FY2025 sales of $260.000 million-$290.000 million vs $270.600 million analyst estimate.